NCT05138939 is a NA clinical trial of Red wine A in Vascular Function; Platelet Aggregation, sponsored by University of California, Davis.

Who is sponsoring NCT05138939?

NCT05138939 is sponsored by University of California, Davis.

What drugs are being tested in NCT05138939?

Interventions in NCT05138939: Red wine A, Red wine B, Control.

What condition does NCT05138939 study?

NCT05138939 studies Vascular Function; Platelet Aggregation.

Is NCT05138939 still recruiting?

NCT05138939 is currently completed. Last updated 8 June 2023.

Last reviewed 2023-06-08 · How we verify

NCT05138939

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Japanese Red Wines on Vascular Function in Adult Men

Completed NA Last updated 8 June 2023

What this trial tests

NA trial testing Red wine A in Vascular Function; Platelet Aggregation in 10 participants. Completed in 4 February 2023.

Timeline

17 November 2021

Primary endpoint
4 February 2023

4 February 2023

Quick facts

Lead sponsor	University of California, Davis
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	other
Enrollment	10
Start date	17 November 2021
Primary completion	4 February 2023
Estimated completion	4 February 2023
Sites	1 location across United States

Drugs / interventions tested

Red wine A
Red wine B
Control

Conditions studied

Vascular Function; Platelet Aggregation — all drugs for Vascular Function; Platelet Aggregation →

Sponsor

University of California, Davis

Who can join

Adults 50 to 70, male only, with Vascular Function; Platelet Aggregation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall objective of this study is to investigate the effects of different types of red wine on markers of endothelial function and platelet aggregation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Effect of Hokkaido Red Wines on Vascular Outcomes in Healthy Adult Men: A Pilot Study.
Charoenwoodhipong P, Holt RR, Keen CL, Hedayati N, et al · · 2023 · cited 3× · PMID 37764837 · DOI 10.3390/nu15184054

Verify or expand the search:

Other University of California, Davis trials

Trials by the same sponsor.

NCT07024498 — Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment · NA · not yet recruiting
NCT07322133 — Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE) · Phase 4 · recruiting
NCT07384767 — Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing · Phase 2 · not yet recruiting
NCT07267494 — Image-Guided Herniorrhaphy Study · NA · not yet recruiting
NCT04614714 — Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants · Phase 2, PHASE3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05138939 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, Davis
Last refreshed: 8 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05138939.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing